Yakira Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Yakira Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,924	Closed	-$220K	–	357
2023 Q4	$220K	Buy	+21,924	New	+$99.5K	0.07%	129

Yakira Capital Management's GRCL Position: Q1 2024 in Review

Yakira Capital Management sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2024, closing a stake of 21,924 shares — an estimated $220K sold.

Yakira Capital Management first reported a position in GRCL in Q4 2023 and held it in 1 quarter. The position peaked at $220K in Q4 2023. 0 funds tracked by Wall St. Rank hold GRCL as of Q1 2024.

Yakira Capital Management reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Yakira Capital Management sold 21,924 Gracell Biotechnologies Inc. American Depositary Shares shares in Q1 2024, an estimated $220K.
Yakira Capital Management first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q4 2023 and held it in 1 quarter.
Yakira Capital Management's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $220K in Q4 2023.
0 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2024.

Based on Yakira Capital Management's 13F filing for Q1 2024, filed 14 May 2024.